Grupo Supley, which controls the brands Max Titanium and Probiotica, acquires the brand Dr. Peanut at the end of December and thus expects to anticipate the goal of 1 Billion in revenue for 2023. Headquartered in Matão, in the interior of São Paulo, the company closed 2022 with revenue in excess of BRL 650 million.
Upon joining the group, Dr. Peanut should see sales jump from BRL 80 million to BRL 200 million in 2023, taking advantage of Supley’s distribution and sales synergies.
“With Dr. Peanut we have become the best ecosystem of brands, products and experiences that deliver performance and health, with the sole objective of accelerating business opportunities for our customers through strong, highly competitive, desired brands and a supply chain that combines efficiency and constant investments in structure and technology”, explains Alberto Moretto, managing partner of Grupo Supley.
In addition to the market expansion power, the synergy of purpose between the companies was an important factor in the acquisition, which is part of the robust investment plan of 40 million reais announced in 2022.
Mariane Morelli, managing partner of the Group, says:
“For us, believing in the transforming power of Nutrition and Sport in people’s lives means going beyond delivering the best products! It’s seeking a common purpose, creating real connections and telling stories that inspire. Another investment that confirms our leadership and constant increase in market share.”
Founded 6 years ago, Dr. Peanut stands out in the sector, having shown exponential growth of 3 digits in the last 24 months and brings with it the Dr. Peanut Turma da Mônica, licensed by Maurício de Souza Produções.
Lucas Castro da Cruz, Founding Partner, explains:
“Since our founding in 2017, we have changed the dynamics of the category, re-signified the way of consumption, with innovation and quality when delivering products that provide unique moments for consumers and add sales results for all shopkeepers.”
And precisely to further accelerate its market penetration that Dr. Peanut welcomed the negotiation, in which its shareholders continue to lead the operation, being able to contribute to the business expansion plans.
Rodrigo Cardoso, Partner/CEO of Dr. Peanut, comments:
“The main objective of this movement is to further accelerate the capillarity of the Dr. Peanut and become an even more relevant brand for our customers and consumers.”
Want to know more about the news? Don’t forget to followADNEWS on social networks and stay on top of everything!
The post With the acquisition of the Dr Peanut brand, Grupo Supley anticipates a 1BI billing target appeared first on ADNEWS.
